Abstract
The iron kinetic model described by Ricketts et al was used to study haemopoiesis in chronic myelofibrosis. The clearance of 59Fe-labelled transferrin from the plasma was analysed to quantify total, effective, and ineffective erythropoiesis, denoted by the terms marrow iron turnover (MIT), red cell iron turnover (RCIT), and per cent ineffective iron turnover (IIT%), respectively, in 12 cases of this disease. The patterns obtained were variable: values for MIT ranged from 24.4 to 510 mumol/l blood/day; those for RCIT from 0.4 to 119 mumol/l blood/day; and those for IIT% from 67 to 98%. One noteworthy feature was the presence in two cases of functional erythroid hypoplasia; these were characterised by severely reduced values for MIT (24.4 and 28 mumol/l blood/day) and RCIT (0.4 and 8 mumol/l blood/day.) A systematic study of the erythrokinetic features of myelofibrosis may indicate that erythroid hypoplasia is a more common cause of anaemia in this disease than has been previously recognised.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barosi G., Baraldi A., Berzuini A., Mascaretti L., Palestra P., Polino G., Ramella S., Rossi F., Spriano P., Cavill I. The influence of regional haematocrit on "in vivo" ferrokinetic measurements. Haematologica. 1984 Jul-Aug;69(4):410–420. [PubMed] [Google Scholar]
- Barosi G., Berzuini C., Liberato L. N., Costa A., Polino G., Ascari E. A prognostic classification of myelofibrosis with myeloid metaplasia. Br J Haematol. 1988 Dec;70(4):397–401. doi: 10.1111/j.1365-2141.1988.tb02507.x. [DOI] [PubMed] [Google Scholar]
- Barosi G., Cazzola M., Frassoni F., Orlandi E., Stefanelli M. Erythropoiesis in myelofibrosis with myeloid metaplasia: recognition of different classes of patients by erythrokinetics. Br J Haematol. 1981 Jun;48(2):263–272. doi: 10.1111/j.1365-2141.1981.tb08459.x. [DOI] [PubMed] [Google Scholar]
- Bentley S. A., Murray K. H., Lewis S. M., Roberts P. D. Erythroid hypoplasia in myelofibrosis: a feature associated with blastic transformation. Br J Haematol. 1977 May;36(1):41–47. doi: 10.1111/j.1365-2141.1977.tb05753.x. [DOI] [PubMed] [Google Scholar]
- Cavill I., Ricketts C., Napier J. A., Jacobs A., Trevett D., Bishop R. D. The measurement of 59Fe clearance from the plasma. Scand J Haematol. 1976 Sep;17(3):160–166. doi: 10.1111/j.1600-0609.1976.tb01171.x. [DOI] [PubMed] [Google Scholar]
- Craig A., Geary C. G., Love E. M., Liu-Yin J. Red cell hypoplasia, thrombocytosis, and leucocytosis: myelodysplastic and proliferative syndrome. J Clin Pathol. 1988 Nov;41(11):1168–1170. doi: 10.1136/jcp.41.11.1168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dessypris E. N., McKee C. L., Jr, Metzantonakis C., Teliacos M., Krantz S. B. Red cell aplasia and chronic granulocytic leukaemia. Br J Haematol. 1981 Jun;48(2):217–225. doi: 10.1111/j.1365-2141.1981.tb08455.x. [DOI] [PubMed] [Google Scholar]
- Njoku O. S., Lewis S. M., Catovsky D., Gordon-Smith E. C. Anaemia in myelofibrosis: its value in prognosis. Br J Haematol. 1983 May;54(1):79–89. doi: 10.1111/j.1365-2141.1983.tb02069.x. [DOI] [PubMed] [Google Scholar]
- Pettit J. E., Lewis S. M., Nicholas A. W. Transitional myeloproliferative disorder. Br J Haematol. 1979 Oct;43(2):167–184. doi: 10.1111/j.1365-2141.1979.tb03739.x. [DOI] [PubMed] [Google Scholar]
- Ricketts C., Jacobs A., Cavill I. Ferrokinetics and erythropoiesis in man: the measurement of effective erythropoiesis, ineffective erythropoiesis and red cell lifespan using 59Fe. Br J Haematol. 1975 Sep;31(1):65–75. doi: 10.1111/j.1365-2141.1975.tb00833.x. [DOI] [PubMed] [Google Scholar]